Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis

被引:12
|
作者
Duong, Nikki K. [1 ,2 ]
Shrestha, Shreesh [1 ,2 ]
Park, Dan [1 ,2 ]
Shahab, Omer [1 ,2 ]
Fagan, Andrew [1 ,2 ]
Malpaya, Zenaida [1 ,2 ]
Gallagher, Mary L. [1 ,2 ]
Morris, April [1 ,2 ]
Davis, Brian C. [1 ,2 ]
Bajaj, Jasmohan S. [1 ,2 ]
机构
[1] Virginia Commonwealth Univ, Richmond, VA 23284 USA
[2] Cent Virginia Vet Healthcare Syst, Richmond, VA 23249 USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 02期
关键词
FORM SCALE; LACTULOSE;
D O I
10.14309/ajg.0000000000001550
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
INTRODUCTION: Bowel movement (BM) frequency is used to titrate lactulose for hepatic encephalopathy (HE). However, stool consistency using the Bristol stool scale (BSS, 0-7) is often ignored. METHODS: The study included pre-BSS and post-BSS cohorts. BSS was incorporated into decision-making after training in outpatients with cirrhosis. Two to 3 BMs/d and BSS 3-4 were considered normal, whereas the rest were considered high or low; concordance between the metrics was evaluated. Medication changes and 6-month admissions were compared between this group (post-BSS) and a comparable previous group (pre-BSS). Concordance and regression analyses for all-cause admissions and H E-related admissions were performed, and comparisons were made for HE-related medication stability. In the longitudinal analysis, an outpatient group seen twice was analyzed for BSS and BMs. RESULTS: In the post-BSS cohort, 112 patients were included with only 46% BSS and BMs concordance and modest BSS/BMs correlation (r = 0.27, P = 0.005). Compared with a pre-BSS cohort (N = 114), there was a lower 6-month total (4% vs 0.36%, P< 0.001) or HE-related admission (1% vs 0.12%, P= 0.002). Regression showed model for end-stage liver disease (odds ratio [OR]: 1.10, P= 0.003) and pre-BSS/post-BSS (OR: 0.04, P< 0.001) for all-cause admissions and HE (OR: 3.59, P= 0.04) and preera/postera (OR: 0.16, P = 0.02) for HE-related admissions as significant. HE medication regimens were more stable post-BSS vs pre-BSS (32% vs 20%, P = 0.04), which was due to patients with BSS > BMs (P= 0.02). In the longitudinal analysis, 33 patients without medication changes or underlying clinical status changes were tested 36 +/- 24 days apart. No changes in BSS (P = 0.73) or BMs (P = 0.19) were found. DISCUSSION: BSS is complementary and additive to BM frequency, can modulate the risk of readmissions and stabilize HE-related therapy changes in outpatients with cirrhosis, and could help personalize HE management.
引用
收藏
页码:295 / 300
页数:6
相关论文
共 50 条
  • [21] Zinc deficiency complicated by hepatic encephalopathy in hepatic cirrhosis patients
    Shaposhnikova, Natalya
    Drozdov, Vladimir
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 : 68 - 68
  • [22] Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning
    Saboo, Krishnakant
    Petrakov, Nikita, V
    Shamsaddini, Amirhossein
    Fagan, Andrew
    Gavis, Edith A.
    Sikaroodi, Masoumeh
    McGeorge, Sara
    Gillevet, Patrick M.
    Iyer, Ravishankar K.
    Bajaj, Jasmohan S.
    JOURNAL OF HEPATOLOGY, 2022, 76 (03) : 600 - 607
  • [23] Validation of the Bristol Stool Form Scale into Romanian
    Chira, Alexandra
    Dumitrascu, Dan L.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2015, 24 (04) : 539 - 540
  • [24] ROLE OF NEUROINFLAMMATION IN IN THE PATHOGENESIS OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH ACUTE LIVER FAILURE AND IN PATIENTS WITH CIRRHOSIS WITH HEPATIC ENCEPHALOPATHY
    Dhiman, Radha K.
    Chopra, Madhu
    Premkumar, Madhumita
    Chakraborti, Anuradha
    Vashista, Rakesh K.
    Duseja, Ajay K.
    Chawla, Yogesh K.
    HEPATOLOGY, 2022, 76 : S1238 - S1239
  • [25] COMPARISON OF THE BRISTOL STOOL FORM SCALE AND THE MODIFIED BRISTOL STOOL FORM SCALE FOR CHILDREN WHEN USED BY PEDIATRIC GASTROENTEROLOGY PROVIDERS
    Self, Mariella M.
    Chumpitazi, Bruno P.
    Czyzewski, Danita I.
    McMullen, Meagan
    Shulman, Robert J.
    GASTROENTEROLOGY, 2020, 158 (06) : S359 - S360
  • [26] GREATER AGREEMENT WITH THE MODIFIED BRISTOL STOOL SCALE FOR CHILDREN VS THE BRISTOL STOOL FORM SCALE WHEN UTILIZED BY CHILDREN AND PROVIDERS
    Orozco, James
    Grisales, Sara
    Self, Mariella M.
    Chumpitazi, Bruno
    Czyzewski, Danita I.
    Berger, Rebecca
    Gonzalez, Clarissa
    Cunha, Amber
    Shulman, Robert J.
    GASTROENTEROLOGY, 2024, 166 (05) : S227 - S227
  • [27] Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis
    Haj, Mona
    Rockey, Don C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (05): : 723 - 728
  • [28] Performance of the Hepatic Encephalopathy Scoring Algorithm in a Clinical Trial of Patients With Cirrhosis and Severe Hepatic Encephalopathy
    Hassanein, Tarek
    Blei, Andres T.
    Perry, William
    Hilsabeck, Robin
    Stange, Jan
    Larsen, Fin S.
    Brown, Robert S., Jr.
    Caldwell, Stephen
    McGuire, Brendan
    Nevens, Frederik
    Fontana, Robert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (06): : 1392 - 1400
  • [29] MINIMAL HEPATIC ENCEPHALOPATHY IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS
    Maric, Daniela
    Klasnja, Biljana
    Filipovic, Danka
    Brkic, Snezana
    Ruzic, Maja
    Bugarski, Vojislava
    ACTA CLINICA CROATICA, 2011, 50 (03) : 375 - 380
  • [30] Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis
    Rahima A. Bhanji
    Carlos Moctezuma-Velazquez
    Andres Duarte-Rojo
    Maryam Ebadi
    Sunita Ghosh
    Christopher Rose
    Aldo J. Montano-Loza
    Hepatology International, 2018, 12 : 377 - 386